Ποια είναι η τιμή για BillionToOne, Inc. (BLLN)

Η τιμή για BillionToOne, Inc. (BLLN) είναι $99.89

Ποια είναι η κεφαλαιοποίηση αγοράς για BillionToOne, Inc. (BLLN)

Η κεφαλαιοποίηση αγοράς για BillionToOne, Inc. (BLLN) είναι $4.59B

BillionToOne, Inc. (BLLN) Τιμή και Κεφαλαιοποίηση Αγοράς

BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions. Central to their operations is a cutting-edge molecular counting platform, meticulously engineered to identify and measure individual DNA molecules, thereby significantly enhancing the precision of disease detection. Their product portfolio includes: UNITY Complete: A non-invasive prenatal screen that assesses a fetus's risk for aneuploidies, recessive genetic conditions, and fetal antigens, all from a simple maternal blood sample. Northstar Select: A liquid biopsy test designed to pinpoint specific mutations present in tumors, encompassing deletions, insertions, and point mutations. Northstar Response: A diagnostic tool that enables continuous tracking of cancer progression through detailed methylation assessment. Established in 2016, BillionToOne, Inc. conducts its operations from its headquarters located in Menlo Park, California.

Η τιμή για BLLN	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$112,021 $4.59B	NVDA	$5.152T	+112,045.64%
$98,640.39 $4.59B	AAPL	$4.537T	+98,649.80%
$90,629.77 $4.59B	GOOG	$4.169T	+90,630.29%
$79,189.16 $4.59B	MSFT	$3.642T	+79,177.00%
$60,977.70 $4.59B	AMZN	$2.805T	+60,945.34%

Η τιμή για BLLN

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$112,021 $4.59B